crsp stock on wild ride after fda's historic approval. these gene editing treatments could be next.
Published 8 months ago • 113K plays • Length 16:31Download video MP4
Download video MP3
Similar videos
-
3:39
crispr therapeutics ceo: science in gene editing is moving at break-neck speed
-
14:45
is gene editing the future?
-
15:50
is now the time to invest in genome editing - crispr therapeutics
-
12:37
can crispr therapeutics (crsp) deliver a one time cure for genetics diseases? #ctx001 #crsp #crispr
-
12:22
gene editing updates | crispr, intellia, and beam
-
19:58
大马的再生能源领域,有前景吗?再生能源的股票有哪些? | greatech| cypark| solarvest| 太阳能| klse | traderseeds 【股票ep12】
-
7:37
crispr's next advance is bigger than you think | jennifer doudna | ted
-
11:16
gene editing: how crispr will change everything & create designer babies
-
5:27
crispr therapeutics ceo talks winning fda approval for sickle cell anemia treatment
-
12:25
new gene editing stock [should we buy?]
-
26:15
why crsp's sickle cell disease therapy is the start of a revolution (trillion-dollar opportunity?)
-
26:08
how is mythic therapeutics transforming the adc space?
-
1:30:52
charging forward: an investor’s guide to the ev market landscape
-
4:02
what will crispr therapeutics stock do next?
-
15:50
intellia stock vs crispr stock: the winner is?
-
6:01
fmr. fda commissioner dr. scott gottlieb on fda approval of crispr treatment, cvs' new drug model
-
8:09
healthcare and biotech updates: growth, innovations, and breakthroughs
-
7:34
fda will approve this crispr drug
-
6:53
is now the time to buy crispr therapeutics (crsp) ?
-
0:56
big ideas 2019: crispr genome-editing for human therapeutics | ark invest
-
8:29
why crispr therapeutics could skyrocket: a must-buy stock for 2024!
-
17:54
ctx112: next-gen car-t therapy - potential, risks & market outlook (crispr therapeutics)